![Daniel Swisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 429 371 $ al 30/06/2026
El Sr. Daniel N. Swisher es presidente y director de operaciones de Jazz Pharmaceuticals Plc, presidente y director de operaciones de Jazz Pharmaceuticals, Inc. y director independiente de Corcept Therapeutics, Inc. y presidente de Cerus Corp. Forma parte del Consejo de Administración de Corcept Therapeutics, Inc. El Sr. Swisher trabajó anteriormente como Presidente, Director General, Secretario y Director de Sunesis Pharmaceuticals, Inc. y como Vicepresidente Senior de Ventas y Marketing de ALZA Corp. Se licenció en la Universidad de Yale y obtuvo un MBA en la Stanford Graduate School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERUS CORPORATION 0,07 % | 03/06/2025 | 147.045 ( 0,07 % ) | 429 371 $ | 30/06/2026 |
| 21/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Director/Miembro de la Junta | 18/06/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Director Ejecutivo | 04/02/2026 |
| CERUS CORPORATION | Presidente | 16/06/2025 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Miembro de la Junta | 17/09/2024 |
| JAZZ PHARMACEUTICALS PLC | Presidente | 01/10/2023 |
| VIRACTA THERAPEUTICS, INC. | Director Ejecutivo | 31/12/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
